In this scientific research, thermally stable nickel nanoparticles were synthesized and characterized. Nickel nanoparticles were synthesized using phenol –formaldehyde by chemical method followed by calcination. The polymer metal complex was confirmed by FTIR and NMR. The spherical morphology of nickel nanoparticles confirmed by SEM. The crystallographic structure is confirmed by XRD and size of cobalt nanoparticles is 24.0 nm. The TGA analysis was performed over a range of 29-600OC. The TGA thermograph predicts mass decomposition of 11%, for nickel phenol-formaldehyde nanocomposite. The decomposition rate of composites is very low 2% weight loss per 100OC increment in temperature.

False positives on multiparametric (mp)-MRI result in a large number of unnecessary biopsies in men with clinically insignificant diseases. This study investigates whether quantitative diffusion MRI can improve differentiation between false positives, true positives and normal tis-sue. Twenty-three patients underwent mp-MRI and Vascular, Extracellular and Restricted Diffu-sion for Cytometry in Tumours (VERDICT)-MRI, followed by transperineal biopsy. The patients were categorised into two groups following biopsy: (1) significant cancer - true positive (2) atro-phy/inflammation/high-grade prostatic intraepithelial neoplasia (PIN) - false positive. The clinical apparent diffusion coefficient (ADC) values of the lesions were obtained, and the intravoxel inco-herent motion (IVIM), diffusion kurtosis imaging (DKI) and VERDICT models were fitted using a deep learning approach. Significant differences (p < 0.05) between true positive and false positive lesions were found in ADC, IVIM perfusion fraction (f) and diffusivity (D), DKI diffusivity (DK) and kurtosis (K) and VERDICT intracellular volume fraction (fIC), extracellular-extravascular vol-ume fraction (fEES) and diffusivity (dEES) values. Significant differences between false positives and normal tissue were only found for the VERDICT fIC. These results demonstrate that model-based diffusion MRI could reduce the number of unnecessary biopsies due to false positive prostate lesions and shows promising sensitivity to benign diseases that mimic cancer.